Long Term Outcomes On Pterygium Excision With Conjunctival Autograft With Fibrin Glue
Published 2024 - 42nd Congress of the ESCRS
Reference: PO909 | Type: Free paper | DOI: 10.82333/mj3d-9h42
Authors: Justine Griffith* 1 , Loredana Smarandache 1 , Sathish Srinivasan 2
1University Hospital Ayr,Ayr,United Kingdom, 2University Hospital Ayr,Ayr,United Kingdom;University of the West of Scotland,Glasgow,United Kingdom
Purpose
To report the long-term outcomes on graft stability and recurrence rates following pterygium excision with conjunctival autograft (PECA) with fibrin glue for primary pterygium.
Setting
Single center, single surgeon, retrospective study.
Methods
Medical records of patients that underwent PECA with fibrin glue for primary pterygium by a single surgeon (SS) from 2010 to 2023 at University Hospital Ayr, Ayr, Scotland. All surgical procedure was performed under local anesthesia and in all cases fibrin glue (no sutures) was used to secure the conjunctival autograft to the bare sclera. Postoperatively all subjects were treated with topical antibiotics for 4 weeks and steroids were slowly tapered based on the clinical response. Data on demographics, graft stability, intra and postoperative complications, and recurrence were collected. Patients were excluded if complete medical records were unavailable for data collection.
Results
Conclusions
Pterygium excision with conjunctival graft with fibrin glue is a safe and effective treatment option for primary pterygium with a very low recurrence rate. Fibrin glue is a safe and effective alternative to sutures. These patients need long-term follow-up to monitor steroid-induced pressure spikes.